Home » GUAVA TECHNOLOGIES ANNOUNCES NEW LINE OF ANTIBODY REAGENTS OPTIMIZED FOR GUAVA SYSTEMS
GUAVA TECHNOLOGIES ANNOUNCES NEW LINE OF ANTIBODY REAGENTS OPTIMIZED FOR GUAVA SYSTEMS
Guava Technologies, Inc., a leading developer of cost-effective and accessible
cell-analysis systems for life science research, drug discovery, development
and clinical diagnostics, today announced the introduction of Express Cell Surface
Antibodies, a new line of antibody reagents designed to identify subsets of
hematopoetic-derived cells by their patterns of protein expression. This is
the first of several new reagent lines that Guava intends to introduce this
year for use by life sciences researchers.
International
News Service
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May